PATENT CLAIM ANALYSIS

Application Number: 16270379
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-06
Patent Classification: ["435", "007400"]

Abstract:
Methods for determining the risk of developing acute renal failure in a human subject by measuring human neutrophil gelatinase-associated lipocalin (NGAL) are provided.

Claim (Index 22):
The method according to  claim 21 , wherein step (c) is performed at an interval subsequent to step (a).

Metadata:
- Claim Count in Document: 5.0
- Percentile: 99.0
- Lexical Diversity: 1.04
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12531986', '12817566', '12143769', '11123364', '12922047']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6070391162317846
- 35 USC 102 Novelty (BERT): 0.5552443025189812
- Combined Prediction Score: 0.6018596348605043
- Mean Citation Score: 283.106096
- Max Citation Score: 386.4195
- Similarity Product: 192.5845586149693

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test